These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Differences in biodistribution between 99mTc-depreotide, 111In-DTPA-octreotide, and 177Lu-DOTA-Tyr3-octreotate in a small cell lung cancer animal model. Schmitt A, Bernhardt P, Nilsson O, Ahlman H, Kölby L, Forssell-Aronsson E. Cancer Biother Radiopharm; 2005 Apr; 20(2):231-6. PubMed ID: 15869461 [Abstract] [Full Text] [Related]
27. Use of 111In-DTPA-octreotide scintigraphy in the diagnosis of neuroendocrine and non-neuroendocrine tumors of the lung. Preliminary results. Oliaro A, Filosso PL, Bello M, Casadio C, Angusti T, Masaneo I, Maggi G, Bisi G. J Cardiovasc Surg (Torino); 1997 Jun; 38(3):313-5. PubMed ID: 9219485 [Abstract] [Full Text] [Related]
33. Gluc-Lys([18F]FP)-TOCA PET in patients with SSTR-positive tumors: biodistribution and diagnostic evaluation compared with [111In]DTPA-octreotide. Meisetschläger G, Poethko T, Stahl A, Wolf I, Scheidhauer K, Schottelius M, Herz M, Wester HJ, Schwaiger M. J Nucl Med; 2006 Apr; 47(4):566-73. PubMed ID: 16595488 [Abstract] [Full Text] [Related]